These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 939474

  • 1. Paradoxical reversal of the suppressed potassium secretion during treatment with combinations of antikaluretic agents (spironolactone, canrenone, triamterene, amiloride); a possible site of action in Henle's loop.
    Radó JP, Sawinsky I, Juhos E.
    Horm Metab Res; 1976 May; 8(3):250-1. PubMed ID: 939474
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Amiloride (MK-870), a new antikaluretic diuretic. Comparison to other antikaluretic diuretics in patients with liver disease and ascites.
    Yamada S, Reynolds TB.
    Gastroenterology; 1970 Dec; 59(6):833-41. PubMed ID: 5486268
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Pharmacology of potassium-sparing diuretics: amiloride and triamterene].
    Rorive G, Bovy P.
    Coeur Med Interne; 1978 Dec; 17(2):207-15. PubMed ID: 350481
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Opposite effects of spironolactone and amiloride on potassium excretion in a patient with ascites due to liver cirrhosis.
    Radó JP, Juhos E.
    Endokrinologie; 1976 Jul; 67(3):377-9. PubMed ID: 976213
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Spirolactones and potassium-sparing diuretics].
    Thibonnier M, Corvol P, Milliez P.
    Rev Prat; 1978 Nov 11; 28(51):4021-4, 4027-8, 4031-2. PubMed ID: 741188
    [No Abstract] [Full Text] [Related]

  • 14. Canrenone and androgen receptor-active materials in plasma of cirrhotic patients during long-term K-canrenoate or spironolactone therapy.
    Andriulli A, Arrigoni A, Gindro T, Karbowiak I, Buzzetti G, Armanini D.
    Digestion; 1989 Nov 11; 44(3):155-62. PubMed ID: 2697627
    [Abstract] [Full Text] [Related]

  • 15. Clinical evaluation of amiloride, a potassium-sparing diuretic.
    Lant AF, Smith AJ, Wilson GM.
    Clin Pharmacol Ther; 1969 Nov 11; 10(1):50-63. PubMed ID: 4884296
    [No Abstract] [Full Text] [Related]

  • 16. Significance of hypokalaemia due to diuretics.
    Leemhuis MP, Struyvenberg A.
    Neth J Med; 1973 Nov 11; 16(1):18-28. PubMed ID: 4572424
    [No Abstract] [Full Text] [Related]

  • 17. Potassium-sparing diuretics: spironolactone v. triamterene and amiloride.
    Drug Ther Bull; 1972 Apr 14; 10(8):30-2. PubMed ID: 5038791
    [No Abstract] [Full Text] [Related]

  • 18. Clinical use of the potassium-sparing diuretics.
    Krishna GG, Shulman MD, Narins RG.
    Semin Nephrol; 1988 Dec 14; 8(4):354-64. PubMed ID: 3068756
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Comparative study of diuretic drugs used in cirrhotic and ascitic patients].
    Lennhoff M, Duhalt R, Peña JC.
    Rev Invest Clin; 1968 Dec 14; 20(2):165-80. PubMed ID: 5721631
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.